Research led by Rockefeller University in New York investigated alternate targets for monoclonal antibodies to combat SARS-CoV-2 infections.
In the course of Alzheimer's disease, two proteins called amyloid and tau accumulate in the brain. A DZNE study with more than 200 participants now provides insights into the interaction of these pathological phenomena. The ...
Mar 30, 2022
0
18
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
(HealthDay)—There's good news for the millions of Americans who've already received a dose or two of Moderna's COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months.
Apr 6, 2021
0
128
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy ...
Jul 15, 2020
0
314
A new cancer clinical trial has opened at the M Health Fairview University of Minnesota Medical Center that leverages the groundbreaking research on stem cells and natural killer (NK) cells done at the Masonic Cancer Center ...
Oct 21, 2019
0
4
Treating cancer more selectively and more effectively—this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the ...
Aug 8, 2019
0
24
A family of cancer suppressive proteins, known as TET proteins, help regulate gene activity via their influence on chromosomal architecture. However, until now it wasn't entirely clear how genes were activated by TET proteins ...
Apr 26, 2019
0
62
The University of Canterbury's Chair of Cancer Epidemiology, Professor Ann Richardson, is on a mission to discover if there is a link between common viruses and breast cancer.
Jun 20, 2018
0
5
New research by a team of health experts at the University of Nottingham has found evidence that being in a positive mood on the day of your flu jab can increase its protective effect.
Sep 25, 2017
0
961
